Roland F. Staack

Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

Frank T. Peters, Simone Schaëfer, Roland F. Staack et al. · Journal of Mass Spectrometry · 2003 · 171 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +13

Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time‐of‐flight mass spectrometry

Luca Signor, Emmanuel Varesio, Roland F. Staack et al. · Journal of Mass Spectrometry · 2007 · 112 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography–mass spectrometry

Roland F. Staack, Giselher Fritschi, Hans H. Maurer · Journal of Chromatography B · 2002 · 108 citations

Pharmacy, Pharmacology, Toxicology +16

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +13

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +16